Stocks
Vaxxinity, Inc.VAXX
OTCHealthcareBiotechnology$0.00-99.00%
Clinical‑stage biotechnology company developing synthetic peptide vaccines aimed at treating chronic diseases and neurological disorders, including Alzheimer’s and Parkinson’s, as well as certain infectious diseases. Its platform seeks to stimulate targeted immune responses using proprietary peptide...
Market Cap: $12,67852W Range: $0.00 – $0.05
Congressional Interest in Vaxxinity, Inc. (VAXX)
1 member of Congress has disclosed 1 trade in Vaxxinity, Inc. (VAXX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading VAXX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-12-20 | Rick Scott | sell | $1K – $15K |